Explore

Rapid ReadRapid Read
NIH Awards Boston University $57.5 Million for Infectious Diseases Research

NIH Awards Boston University $57.5 Million for Infectious Diseases Research

The National Institutes of Health (NIH) has awarded $57.5 million to Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL). This five-year grant, provided by the National Institute of Allergy and Infectious Diseases, is intended to support NEIDL's mission to understand and combat major threats to domestic and global health. The funding will directly cover the lab's operations, including biosecurity systems, biosafety programs, facility maintenance, regulatory compliance, specialized biocontainment training, and advanced technical research support services. NEIDL, one of only two national biocontainment labs in the United States, operates at Biosafety Level 4 (BSL-4), enabling researchers to study highly dangerous pathogens such as Ebola, Marburg, Zika, and SARS-CoV-2 in a secure environment. This award follows a previous $7.5 million NIH grant in 2024 for facility modernization.
Rapid ReadRapid Read
Scientists Discover Ancient Peptide with Enhanced Antibacterial Properties Using AI

Scientists Discover Ancient Peptide with Enhanced Antibacterial Properties Using AI

Scientists have utilized artificial intelligence (AI) and an evolutionary approach to uncover an ancient version of the protein lactoferrin, found in tears and breast milk, that possesses enhanced antibacterial properties. This protein, which emerged 160 million years ago, evolved from an ancestral gene called transferrin. Researchers, including Matthew F. Barber, PhD, associate professor of biology at the University of Oregon, reconstructed amino acid sequences from early lactoferrin and used AI program AlphaFold to predict structural evolution. They identified a highly positive charge on the surface of lactoferrin's ancestors, indicating its antibacterial function evolved after separating from transferrin. Notably, a specific amino acid substitution (arginine instead of glutamine) in non-human great apes' lactoferricin, a peptide derived from lactoferrin, significantly improved its antimicrobial activity against bacteria like Staphylococcus aureus. By engineering this substitution into human lactoferrici...
Rapid ReadRapid Read
NAIST Study Uncovers Bacteriophage Protein Mechanism, Paving Way for New Antibiotics

NAIST Study Uncovers Bacteriophage Protein Mechanism, Paving Way for New Antibiotics

A research team led by Assistant Professor Hidetaka Kohga at the Nara Institute of Science and Technology (NAIST) in Japan has published a study detailing how a bacteriophage protein, SglPP7, inhibits MurJ, a crucial lipid transporter in bacteria. The study, published in PLOS Biology on October 27, 2026, utilized cryo-electron microscopy, targeted protein mutations, bacterial cell lysis experiments, and computer simulations to reveal the molecular interactions. The findings indicate that SglPP7 binds to MurJ, stabilizing it in an outward-facing conformation, which prevents the necessary structural changes for lipid transport. This research also compared SglPP7's mechanism with two other phage proteins, LysM and SglCJ3, finding that despite different binding methods, all three stabilize MurJ in a similar conformation. This suggests a convergent evolutionary path towards inhibiting the same bacterial target through diverse molecular strategies. The increasing global threat of drug-resistant bacteria necessit...
Rapid ReadRapid Read
Pharmacogenomics Advances Personalized Medicine by Linking Genetics to Drug Response

Pharmacogenomics Advances Personalized Medicine by Linking Genetics to Drug Response

Pharmacogenomics is an evolving field that studies how an individual's genetic makeup influences their response to medications. This scientific discipline aims to move healthcare beyond a trial-and-error approach by using genetic information to predict how a patient will react to specific drugs. By analyzing genetic variations, doctors can potentially identify more suitable medications and dosages, thereby reducing adverse side effects and improving treatment efficacy. This approach is particularly beneficial in areas such as antidepressant prescriptions, cardiovascular treatments, and cancer therapies. While not every prescription requires or benefits from pharmacogenomic testing, it offers a more personalized method for healthcare providers to tailor medical treatments to individual patient characteristics. The integration of genomic real-world data, which links genetic information with clinical outcomes from routine care, is crucial for advancing this field. This data allows researchers to connect DNA v...
Rapid ReadRapid Read
U.S. Measles Cases Exceed 5,000, Raising Concerns Ahead of Holidays

U.S. Measles Cases Exceed 5,000, Raising Concerns Ahead of Holidays

More than 5,000 measles cases have been reported across the United States this year, marking a significant surge in the infectious disease. This increase has prompted growing concerns, particularly as the holiday season approaches, a period often associated with increased travel and social gatherings. The current figures indicate a dangerous high for measles cases in the U.S., as reported by NBC News’ Aaron Gilchrist on November 8, 2026. The rapid spread of the disease highlights ongoing public health challenges and the importance of vaccination efforts to control outbreaks. The situation suggests a potential for further escalation if preventative measures are not effectively reinforced.
Rapid ReadRapid Read
Arizona Officials Host Forum on Newly Detected Parasitic Screwworm Threat

Arizona Officials Host Forum on Newly Detected Parasitic Screwworm Threat

Public health experts and community leaders in Arizona are hosting an informational forum to discuss the recent detection of the New World screwworm, a parasitic fly whose larvae feed on the living tissue of warm-blooded animals. The event, titled "Talk About It Tuesdays," will take place on Tuesday, November 10, from 5:30 p.m. to 6:30 p.m. at Drachman Hall Room B109 on the University of Arizona campus, with an online option via Zoom. Officials from the University of Arizona College of Public Health state that the pest has been detected in Arizona, raising concerns among local agricultural and health agencies. Panelists will include health professionals from the Arizona Department of Health Services, the Pima County Health Department, the University of Arizona College of Veterinary Medicine, the Arizona Department of Agriculture, and the Pima Animal Care Center. The forum aims to inform the public on how to protect animals, what to look for when traveling, and how the community can respond to the detection...
Rapid ReadRapid Read
Norovirus Remains Leading Cause of Cruise Ship Outbreaks, Respiratory Pathogens Gaining Ground

Norovirus Remains Leading Cause of Cruise Ship Outbreaks, Respiratory Pathogens Gaining Ground

A meta-analysis published in eClinicalMedicine reveals that norovirus has been the primary cause of infectious-disease outbreaks on cruise ships over the past 57 years. However, respiratory pathogens like influenza and SARS-CoV-2 are increasingly contributing to these outbreaks. The study, led by Peking University researchers, analyzed 107 observational studies covering 619 outbreaks on 236 ships from 1969 to 2026. While the overall risk of outbreaks and related deaths on cruise ships remains relatively low, the unique semi-closed, high-density environment facilitates rapid transmission of infectious agents. Norovirus accounted for the largest percentage of outbreaks since 1995, but SARS-CoV-2 showed a higher infection rate among crew members compared to passengers. The findings indicate a diversification of the epidemiological landscape on cruise ships, with emerging pathogens and distinct infection patterns between passengers and crew.
Rapid ReadRapid Read
Gates Foundation Awards £2 Million Grant to PhaSER Biomedical for Drug Development Acceleration

Gates Foundation Awards £2 Million Grant to PhaSER Biomedical for Drug Development Acceleration

PhaSER Biomedical, a biotech startup, has secured a £2 million grant from the Bill & Melinda Gates Foundation. This two-year renewal funding aims to advance drug discovery for neglected diseases by providing humanized mouse models. The grant will expand access to PhaSER’s 8HUM platform and related translational modeling, which are designed to improve preclinical prediction and reduce species-related failures in drug development. The 8HUM transgenic mouse models are engineered to mimic human drug-metabolizing pathways, offering more human-relevant pharmacokinetic and safety signals earlier in the development process. This is particularly crucial for diseases like tuberculosis, malaria, schistosomiasis, and Chagas disease, which often receive limited commercial investment. The funding also supports collaborative research efforts with global health researchers and the University of Dundee's Drug Discovery Unit.
Rapid ReadRapid Read
Oral Microbes Show Widespread Antibiotic Resistance Genes, Prompting Call for Precision Prescribing in Dentistry

Oral Microbes Show Widespread Antibiotic Resistance Genes, Prompting Call for Precision Prescribing in Dentistry

A recent review published in the Journal of Cellular and Molecular Medicine highlights the increasing prevalence of antibiotic resistance genes in oral microbes, particularly in individuals with gum disease. The review, which synthesizes decades of evidence on antimicrobial resistance in periodontal disease, concludes that current empirical antibiotic prescribing practices in dentistry are accelerating this problem. Dentists are responsible for approximately 10% of antibiotic prescriptions globally, contributing significantly to the development of resistance. The study notes a concerning trend in the U.S., with a 20-year surveillance of 2,193 periodontitis patients showing a fivefold increase in clindamycin-resistant P. gingivalis and a 28-fold increase in amoxicillin resistance between 2019 and 2020 compared to 1999-2000. The review advocates for a fundamental shift towards precision prescribing, based on mapping the full collection of resistance genes in the mouth, known as the periodontal resistome.
Rapid ReadRapid Read
Scientists Advance Phage-Based Treatments to Combat Antibiotic Resistance

Scientists Advance Phage-Based Treatments to Combat Antibiotic Resistance

Researchers have developed a new method to investigate bacteriophages, or phages, which are viruses that infect and kill bacteria. This innovation aims to enhance understanding of how phages function and to engineer them more effectively against harmful bacteria, particularly in the face of rising antibiotic resistance. The method, called Phage Tn-seq (transposon sequencing), allows scientists to pinpoint essential phage genes and insert new genetic material into their genomes rapidly. This approach leverages the 'molecular arms race' between bacteria and phages, utilizing anti-CRISPR proteins carried on transposons to select for phages with specific mutations. The goal is to overcome limitations of current phage study methods, which are often time-consuming or require extensive prior knowledge of the phage's genome. This development is crucial as antibiotic resistance is projected to contribute to over eight million deaths annually by 2050, renewing interest in phage therapies as an alternative to convent...
TrendlineTrendline
New DNA Cartridge Simplifies Detection of Hidden Food Allergens in Food Production

New DNA Cartridge Simplifies Detection of Hidden Food Allergens in Food Production

New DNA Cartridge Simplifies Detection of Hidden Food Allergens in Food Production
Rapid ReadRapid Read
DASH Diet Linked to 76% Lower Stroke Risk in Women, Study Finds

DASH Diet Linked to 76% Lower Stroke Risk in Women, Study Finds

A recent study involving 1,177 older adults, with a median age of 81, has found that women who closely adhered to the DASH (Dietary Approaches to Stop Hypertension) diet experienced a 76% lower relative risk of stroke compared to those who followed it less closely. The study, which tracked participants for an average of 6.6 years, focused on individuals who had not previously experienced a stroke. While the DASH diet is well-known for its role in managing high blood pressure, a major risk factor for stroke, this research specifically investigated its potential to protect the brain. Interestingly, the study did not observe the same significant benefit in men. Researchers suggest that hormonal differences, health habits, and variations in how cardiovascular risk factors develop or are managed between sexes could explain this disparity, though the study was not designed to identify these specific reasons.